EuroPCR: Drug-Coated Stent Better for ACS When Bleed Risk High “BMS can no longer be recommended in these patients”
PARIS — Patients with acute coronary syndrome (ACS) and high bleeding risk do better with a drug-coated stent than a bare metal stent (BMS), a LEADERS FREE substudy found.